Structural determinants of Cav1.3 L-type calcium channel gating

Channels

Volumn 6, Issue 3, 2012, Pages 197-205

  Lieb, Andreas ^a   Scharinger, Anja ^a   Sartori, Simone B ^a   Sinnegger Brauns, Martina J ^a   Striessnig, Jörg ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cacna1d; Gating; Mutagenesis; Species differences

Indexed keywords

CALCIUM CHANNEL L TYPE; LYSINE; ALPHA1D (CAV1.3) L TYPE CALCIUM CHANNEL, HUMAN; ALPHA1D (CAV1.3) L-TYPE CALCIUM CHANNEL, HUMAN; CACNA1D PROTEIN, MOUSE; CACNA1D PROTEIN, RAT; CALCIUM; CALCIUM CHANNEL; ISOPROTEIN; MESSENGER RNA;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CERVICAL GANGLION; CHANNEL GATING; CONTROLLED STUDY; EXON; GENE MUTATION; MALE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; MOUSE; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION;

RATTUS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELL LINE, TRANSFORMED; HUMANS; ION CHANNEL GATING; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864399958     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.21002     Document Type: Article

References (39)

1. Namkung Y, Skrypnyk N, Jeong MJ, Lee T, Lee MS, Kim HL, et al. Requirement for the L-type Ca2+ channel α1D -subunit in postnatal pancreatic beta cell generation. J Clin Invest 2001; 108:1015-22; PMID:11581302.
2. Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, et al. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 2000; 102:89-97; PMID:10929716; http://dx.doi.org/10. 1016/S0092-8674(00)00013-1.
3. Striessnig J, Koschak A. Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin) 2008; 2:233-51; PMID:18719397; http://dx.doi.org/10.4161/chan.2.4.5847.
4. Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nürnberg G, et al. Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci 2011; 14:77-84; PMID:21131953; http://dx.doi.org/10.1038/nn.2694.
5. Mahapatra S, Marcantoni A, Vandael DH, Striessnig J, Carbone E. Are Cav1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin) 2011; 5:219-24; PMID:21406973; http://dx.doi.org/10.4161/chan.5.3.15271.
6. Brandt A, Striessnig J, Moser T. CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells. J Neurosci 2003; 23:10832-40; PMID:14645476.
7. Michna M, Knirsch M, Hoda JC, Muenkner S, Langer P, Platzer J, et al. Cav1.3 α1D Ca2+ currents in neonatal outer hair cells of mice. J Physiol 2003; 553:747-58; PMID:14514878; http://dx.doi.org/10.1113/jphysiol.2003.053256.
8. Bock G, Gebhart M, Scharinger A, Jangsangthong W, Busquet P, Poggiani C, et al. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem 2011; 286:42736-48; PMID:21998310; http://dx.doi.org/10.1074/jbc.M111.269951.
9. Singh A, Gebhart M, Fritsch R, Sinnegger-Brauns MJ, Poggiani C, Hoda JC, et al. Modulation of volt-age- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem 2008; 283:20733-44; PMID:18482979; http://dx.doi.org/10.1074/jbc. M802254200.
10. Huang H, Tan BZ, Shen Y, Tao J, Jiang F, Sung YY, et al. RNA editing of the IQ domain in Cav1.3 channels modulates their Ca2+-dependent inactivation. Neuron 2012; 73:304-16; PMID:22284185; http://dx.doi.org/10.1016/j.neuron.2011. 11.022.
11. Liu X, Yang PS, Yang W, Yue DT. Enzyme-inhibitorlike tuning of Ca2+ channel connectivity with calmodulin. Nature 2010; 463:968-72; PMID:20139964; http://dx.doi.org/10.1038/nature08766.
12. Tan GM, Yu D, Wang J, Soong TW. Alternative splicing at C terminus of CaV1.4 calcium channel modulates calcium-dependent inactivation, activation potential and current density. J Biol Chem 2012; 287:832-47; PMID:22069316; http://dx.doi.org/10.1074/jbc.M111.268722.
13. Koschak A. Impact of gating modulation in CaV1.3 L-type calcium channels. Channels (Austin) 2010; 4:523-5; PMID:21150316; http://dx.doi.org/10.4161/chan. 4.6.12872.
14. Minor DL Jr, Findeisen F. Progress in the structural understanding of voltage-gated calcium channel CaV function and modulation. Channels (Austin) 2010; 4:459-74; PMID:21139419.
15. Xu W, Lipscombe D. Neuronal CaV1.3α1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci 2001; 21:5944-51; PMID:11487617.
16. Yang PS, Alseikhan BA, Hiel H, Grant L, Mori MX, Yang W, et al. Switching of Ca2+-dependent inactivation of Cav1.3 channels by calcium binding proteins of auditory hair cells. J Neurosci 2006; 26:10677-89; PMID:17050707; http://dx.doi.org/10.1523/JNEUROSCI.3236-06.2006.
17. Helton TD, Xu W, Lipscombe D. Neuronal L-type calcium channels open quickly and are inhibited slowly. J Neurosci 2005; 25:10247-51; PMID:16267232; http://dx.doi.org/10.1523/JNEUROSCI.1089-05.2005.
18. Shen Y, Yu D, Hiel H, Liao P, Yue DT, Fuchs PA, et al. Alternative splicing of the Cav1.3 channel IQ domain, a molecular switch for Ca2+-dependent inactivation within auditory hair cells. J Neurosci 2006; 26:10690-9; PMID:17050708; http://dx.doi.org/10.1523/JNEUROSCI.2093-06.2006.
19. Huang H, Tan BZ, Shen Y, Tao J, Jiang F, Sung YY, et al. RNA editing of the IQ domain in Cav1.3 channels modulates their Ca2+-dependent inactivation. Neuron 2012; 73:304-16; PMID:22284185; http://dx.doi.org/10.1016/j.neuron.2011. 11.022.
20. Tadross MR, Dick IE, Yue DT. Mechanism of local and global Ca2+ sensing by calmodulin in complex with a Ca2+ channel. Cell 2008; 133:1228-40; PMID:18585356; http://dx.doi.org/10.1016/j.cell.2008.05.025.
21. Klugbauer N, Welling A, Specht V, Seisenberger C, Hofmann F. L-type Ca2+ channels of the embryonic mouse heart. Eur J Pharmacol 2002; 447:279-84; PMID:12151019; http://dx.doi.org/10.1016/S0014-2999(02)01850-2.
22. Tan BZ, Jiang F, Tan MY, Yu D, Huang H, Shen Y, et al. Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels. J Biol Chem 2011; 286:42725-35; PMID:21998309; http://dx.doi.org/10. 1074/jbc.M111.265207.
23. Tadross MR, Yue DT. Systematic mapping of the state dependence of voltage- and Ca2+-dependent inactivation using simple open-channel measurements. J Gen Physiol 2010; 135:217-27; PMID:20142518; http://dx.doi.org/10.1085/jgp. 200910309.
24. Tadross MR, Ben Johny M, Yue DT. Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Cav1.3 channels. J Gen Physiol 2010; 135:197-215; PMID:20142517; http://dx.doi.org/10.1085/jgp.200910308.
25. Safa P, Boulter J, Hales TG. Functional properties of Cav1.3 α1D L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells. J Biol Chem 2001; 276:38727-37; PMID:11514547; http://dx.doi.org/10. 1074/jbc.M103724200.
26. Griessmeier K, Cuny H, Rötzer K, Griesbeck O, Harz H, Biel M, et al. Calmodulin is a functional regulator of Cav1.4 L-type Ca2+ channels. J Biol Chem 2009; 284:29809-16; PMID:19717559; http://dx.doi.org/10.1074/jbc.M109. 048082.
27. Wahl-Schott C, Baumann L, Cuny H, Eckert C, Griessmeier K, Biel M. Switching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domain. Proc Natl Acad Sci USA 2006; 103:15657-62; PMID:17028172; http://dx.doi.org/10.1073/pnas.0604621103.
28. Singh A, Hamedinger D, Hoda JC, Gebhart M, Koschak A, Romanin C, et al. C-terminal modulator controls Ca2+-dependent gating of Cav1.4 L-type Ca2+ channels. Nat Neurosci 2006; 9:1108-16; PMID:16921373; http://dx.doi.org/10. 1038/nn1751.
29. Hulme JT, Westenbroek RE, Scheuer T, Catterall WA. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc Natl Acad Sci USA 2006; 103:16574-9; PMID:17053072; http://dx.doi.org/10.1073/pnas.0607294103.
30. Fu Y, Westenbroek RE, Yu FH, Clark JP, 3rd, Marshall MR, Scheuer T, et al. Deletion of the distal C terminus of CaV1.2 channels leads to loss of beta-adrenergic regulation and heart failure in vivo. J Biol Chem 2011; 286:12617-26; PMID:21216955; http://dx.doi.org/10.1074/jbc.M110.175307.
31. Danecek P, Nellåker C, McIntyre RE, Buendia- Buendia JE, Bumpstead S, Ponting CP, et al. High levels of RNA-editing site conservation amongst 15 laboratory mouse strains. Genome Biol 2012; 13:26; PMID:22524474; http://dx.doi.org/10.1186/gb-2012-13-4-r26.
32. Gallo A, Thomson E, Brindle J, O'Connell MA, Keegan LP. Micro-processing events in mRNAs identified by DHPLC analysis. Nucleic Acids Res 2002; 30:3945-53; PMID:12235378; http://dx.doi.org/10.1093/nar/gkf516.
33. Payandeh J, Scheuer T, Zheng N, Catterall WA. The crystal structure of a voltage-gated sodium channel. Nature 2011; 475:353-8; PMID:21743477; http://dx.doi.org/10.1038/nature10238.
34. Hoda JC, Zaghetto F, Koschak A, Striessnig J. Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P and W1440X alter channel gating or functional expression of Ca v1.4 L-type Ca2+ channels. J Neurosci 2005; 25:252-9; PMID:15634789; http://dx.doi.org/10.1523/JNEUROSCI.3054-04.2005.
35. Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem 2005; 280:17678-86; PMID:15743764; http://dx.doi.org/10.1074/jbc.M501110200.
36. Frottin F, Martinez A, Peynot P, Mitra S, Holz RC, Giglione C, et al. The proteomics of N-terminal methionine cleavage. Mol Cell Proteomics 2006; 5:2336-49; PMID:16963780; http://dx.doi.org/10.1074/mcp.M600225-MCP200.
37. Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging and selective neuronal vulnerability in Parkinson's disease. Cell Calcium 2010; 47:175-82; PMID:20053445; http://dx.doi.org/10.1016/j.ceca.2009.12.003.
38. Calin-Jageman I, Yu K, Hall RA, Mei L, Lee A. Erbin enhances voltage-dependent facilitation of Cav1.3 Ca2+ channels through relief of an autoinhibitory domain in the Cav1.3 α1-subunit. J Neurosci 2007; 27:1374-85; PMID:17287512; http://dx.doi.org/10.1523/JNEUROSCI.5191-06.2007.
39. Gao L, Blair LA, Salinas GD, Needleman LA, Marshall J. Insulin-like growth factor-1 modulation of CaV1.3 calcium channels depends on Ca2+ release from IP3- sensitive stores and calcium/calmodulin kinase II phosphorylation of the α1-subunit EF hand. J Neurosci 2006; 26:6259-68; PMID:16763033; http://dx.doi.org/10.1523/JNEUROSCI.0481-06.2006.